Lactitol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for lactitol and what is the scope of patent protection?
Lactitol
is the generic ingredient in one branded drug marketed by Braintree Labs and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for lactitol.
Summary for lactitol
| US Patents: | 1 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Clinical Trials: | 7 |
| What excipients (inactive ingredients) are in lactitol? | lactitol excipients list |
| DailyMed Link: | lactitol at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for lactitol
Generic Entry Date for lactitol*:
Constraining patent/regulatory exclusivity:
Dosage:
FOR SOLUTION;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for lactitol
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Indian Council of Medical Research | PHASE4 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | PHASE4 |
| Al-Azhar University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for lactitol
US Patents and Regulatory Information for lactitol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Braintree Labs | PIZENSY | lactitol | FOR SOLUTION;ORAL | 211281-001 | Feb 12, 2020 | DISCN | Yes | No | 10,806,743 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Summary:
Lactitol remains a niche product within the sweetener and pharmaceutical sectors. Its market is driven by applications in sugar-free food products and specific medical uses. The global market is characterized by moderate growth, influenced primarily by sugar reduction trends and regulatory shifts. Revenue streams are stable but limited by competition from alternative sweeteners. R&D investments focus on improving formulation and expanding indications.
What Are the Current Market Dynamics for Lactitol?
Market Drivers
- Increasing demand for sugar substitutes: Rising health concerns over sugar intake have spurred demand for low-calorie sweeteners.[1]
- Applications in pharmaceuticals: Lactitol's laxative properties find uses in bowel management therapies. Some formulations leverage its prebiotic benefits, appealing to the functional food segment.
- Regulatory approvals: Lactitol is GRAS (Generally Recognized As Safe) in the US and approved in the EU, facilitating its use in food and pharma sectors.[2]
Market Restraints
- Limited consumer awareness: Lactitol's recognition remains low compared to stevia or aspartame.
- Cost considerations: Production costs are higher than some competitors, such as sorbitol, constraining margins and application breadth.
- Alternatives: Other non-caloric sweeteners, including erythritol and xylitol, have broader use cases and are more established.
Market Size & Growth
- Global market value (2022): Estimated at approximately USD 150 million.
- Growth rate: Compound annual growth rate (CAGR) projected at 4% from 2023 to 2030.[3]
- Regional distribution: Europe and North America account for over 70% of sales, driven by regulatory acceptance and health trends.
How Do Market Players and Supply Chains Look?
Major Manufacturers
| Company | Market Share | Key Products | Geographic Focus |
|---|---|---|---|
| Ingredion | ~35% | Lactitol powder | North America, Europe |
| Cargill | ~25% | Lactitol solutions | Europe, Asia-Pacific |
| FMC Corporation | ~15% | Lactitol derivatives | Global |
| Others | ~25% | Contract manufacturing | Mainly Asia-Pacific |
Supply Chain Factors
- Raw Materials: Derived primarily from lactose; supply depends on dairy industry stability.
- Manufacturing: Catalytic hydrogenation processes dominate; energy-intensive and regulated.
- Distribution: Mainly via food ingredient suppliers and pharmaceutical distributors.
What Are the Financial Trajectories?
Revenue Trends
- Revenue has grown modestly, with the global market expected to approach USD 200 million by 2030.
- Companies with diversified sweetener portfolios tend to mitigate volatility risks tied specifically to lactitol.
Profitability
- Margins remain thin due to raw material and processing costs.
- R&D expenditure directed at improving yield and reducing production costs is primary profit driver.
Investment & R&D Focus
- Focus on developing new pharmaceutical applications and functional foods.
- Exploration of biotechnological pathways to produce lactitol more efficiently.
What Regulatory and Patent Landscapes Influence Future Growth?
Regulatory Environment
- Recognized as safe by FDA and EFSA.
- Standardized permissible uses limit scope; expansion depends on new safety and efficacy data.
Patent Activity
- Patent protections for manufacturing improvements typically valid through 2030.
- Some companies hold patents on specific formulation methods and proprietary production processes, constraining generic entry.
Summary of Strategic Opportunities and Threats
| Opportunity | Threat |
|---|---|
| Development of novel applications in prebiotics and functional foods | Regulatory delays or restrictions in new markets |
| Cost reduction via process innovation | Intense competition from alternative sweeteners |
| Expansion into emerging markets with rising health awareness | Price sensitivity among commodity buyers |
Key Takeaways
- Lactitol’s market remains constrained by competition, costs, and limited consumer awareness.
- Growth hinges on expanding applications, especially in pharmaceutical and functional foods.
- Regulatory clarity supports market stability; innovations in manufacturing are vital for competitiveness.
- North America and Europe dominate sales; Asia-Pacific presents long-term growth potential.
- Companies investing in product development and process efficiencies position better for future gains.
Frequently Asked Questions
1. What are the primary applications of lactitol?
Lactitol is used as a low-calorie sweetener in sugar-free confections, baked goods, and pharmaceuticals for laxative and prebiotic effects.
2. Why is lactitol preferred in certain medical formulations?
Its laxative efficacy, minimal systemic absorption, and safety profile make it suitable for bowel management and as a prebiotic agent.
3. How does lactitol compare with other sweeteners like sorbitol or erythritol?
Lactitol provides sweetness comparable to sugar but has fewer gastrointestinal side effects than sorbitol. Erythritol is more caloric but better tolerated.
4. What markets hold the most promise for lactitol expansion?
Developed markets with high health awareness; emerging markets with increasing demand for functional foods.
5. What are the main barriers to lactitol's market expansion?
Higher production costs, limited consumer awareness, and strong competition from established sweeteners.
References
More… ↓
